Seonghye Shin

Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate

Hiroaki Matsuno, Masato Tomomitsu, Atsushi Hagino et al. · Annals of the Rheumatic Diseases · 2017 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Enteric fever burden in North Jakarta, Indonesia: a prospective, community-based study

Narain H. Punjabi, Magdarina Destri Agtini, R. Leon Ochiai et al. · The Journal of Infection in Developing Countries · 2013 · 26 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +15

Serum Urate–Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, <scp>Double‐Blind</scp>, <scp>Placebo‐Controlled</scp>, <scp>Dose‐Finding</scp> Trial

Robert Terkeltaub, Jisoo Lee, Jiyoung Min et al. · Arthritis & Rheumatology · 2023 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study

Min‐Chan Park, Hiroaki Matsuno, Jinseok Kim et al. · Arthritis Research & Therapy · 2019 · 21 citations · Full text

Medicine, Clinical Sciences, Immunology +12

Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study

Sang Youb Han, Sun Ae Yoon, Byoung Geun Han et al. · Diabetes Obesity and Metabolism · 2017 · 15 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17